Sign In
Buy BSX
$46.73
+0.730 (+1.59%)
At Close: Jul 31, 2026
After a week of wild swings that rattled portfolios and left investors guessing, Wall Street analysts are already reshuffling their ratings on Friday morning, with some surprising cuts and upgrades ac
Bank of America Corp DE Has $1.43 Billion Stock Holdings in Boston Scientific Corporation $BSX
04:59am, Friday, 31'st Jul 2026
Bank of America Corp DE trimmed its position in Boston Scientific Corporation (NYSE: BSX) by 9.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Co
Penumbra, Inc. Reports Second Quarter 2026 Financial Results
04:05pm, Thursday, 30'th Jul 2026
ALAMEDA, Calif., July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026.
BSX Q2 Earnings Call Highlights WATCHMAN and EP Pressure
11:04am, Thursday, 30'th Jul 2026
BSX faces WATCHMAN and EP pressures as management cuts outlook while highlighting cost savings and new product catalysts for future growth.
Boston Scientific: Attempting The 2027 Reset
10:01am, Thursday, 30'th Jul 2026
Boston Scientific retains my buy rating with a $66 price target, reflecting 44% upside if negative earnings revisions stabilize. BSX has reset expectations, slashing guidance and acknowledging competi
Boston Scientific Q2 Earnings Call Highlights
04:04pm, Wednesday, 29'th Jul 2026
Boston Scientific NYSE: BSX reported second-quarter 2026 revenue growth at the high end of its guidance range and adjusted earnings per share above expectations, but lowered its full-year outlook as i
Boston Scientific Corp (BSX) Q2 2026 Earnings Call Highlights: Strong Growth in Interventional Cardiology and Neuromodulation
02:04pm, Wednesday, 29'th Jul 2026
Organic Sales Growth: 7% in Q2 2026, driven by Interventional Cardiology, Endoscopy, and Neuromodulation.Adjusted EPS: $0.86, a 15% increase, exceeding guidance
Boston Scientific beats second quarter expectations, raises full-year outlook
12:13pm, Wednesday, 29'th Jul 2026
Boston Scientific Corp (NYSE:BSX, XETRA:BSX) reported second quarter results that exceeded analyst expectations for revenue and adjusted earnings, while raising its full-year sales outlook. The medica
Boston Scientific Corporation (BSX) Q2 2026 Earnings Call Transcript
12:03pm, Wednesday, 29'th Jul 2026
Boston Scientific Corporation (BSX) Q2 2026 Earnings Call Transcript
Boston Scientific (BSX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
11:31am, Wednesday, 29'th Jul 2026
Although the revenue and EPS for Boston Scientific (BSX) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall
Boston Scientific Cuts Forecast on Product Slowdown and Competition
11:12am, Wednesday, 29'th Jul 2026
Boston Scientific Corporation (NYSE:BSX) stock is trading lower after the company cut its fiscal 2026 outlook, citing pressures on the Watchman and EP markets.
Boston Scientific Q2 Earnings & Revenues Top Estimates, Stock Climbs
10:06am, Wednesday, 29'th Jul 2026
BSX beats Q2 earnings and revenue estimates as cardiovascular growth, strong APAC and LACA sales, and margin expansion lift shares in pre-market.
Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates
09:26am, Wednesday, 29'th Jul 2026
Boston Scientific (BSX) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.75 per share a year ago.
Boston Scientific beats second quarter expectations, raises full-year outlook
08:07am, Wednesday, 29'th Jul 2026
Boston Scientific Corp (NYSE:BSX, XETRA:BSX) reported second quarter results that exceeded analyst expectations for revenue and adjusted earnings, while...
Boston Scientific Cuts Outlook Ahead of Restructuring
07:23am, Wednesday, 29'th Jul 2026
Boston Scientific logged higher second-quarter results and cut its full-year outlook as it begins a new restructuring plan announced earlier this week.
